Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.70 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.70 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | EGFR | P00533 | 5/20 | 0.44 |
| ▸ | ERBB2 | P04626 | 4/20 | 0.42 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.42 |
| ▸ | IAPP | P10997 | 3/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | TTR | P02766 | 1/20 | 0.38 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL199730 | 0.83 | GABRA1 (1.00) | GABRA1GABRB2CA2IAPPPTPN5 | |
| SCHEMBL16788658 | 0.83 | ALOX5 (0.47) | GABRA1GABRB2CA2ACHEEGFR | |
| SCHEMBL8406789 | 0.82 | GABRA1 (0.52) | GABRA1GABRB2CA2ACHEEGFR | |
| SCHEMBL27561169 | 0.81 | GABRA1 (0.45) | GABRA1GABRB2CA2ACHEEGFR | |
| SCHEMBL11164405 | 0.79 | ALOX5 (0.57) | GABRA1GABRB2EGFRERBB2IAPP | |
| SCHEMBL1450337 | 0.79 | CA2 (0.44) | GABRA1GABRB2CA2ACHEEGFR | |
| SCHEMBL17916374 | 0.79 | GABRA1 (0.52) | GABRA1GABRB2CA2RIPK1TSHR | |
| SCHEMBL28161012 | 0.79 | CA2 (0.44) | GABRA1GABRB2CA2ACHEEGFR | |
| Water SCHEMBL28947715 | 0.78 | GABRA1 (0.90) | GABRA1GABRB2IAPPPTPN5 | |
| Alcohol SCHEMBL28268569 | 0.78 | GABRA1 (0.90) | GABRA1GABRB2IAPPALOX5PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015459-A1 | Method for synthesizing polyphenylene ether | Chem Tech Solutions, LLC (US) | 2026-01-15 | — | — | US | claimed |
| CN-119875110-A | Polyphenylene ether, polyphenylene ether solution, resin film, prepreg, and metal-clad laminate | 旭化成株式会社 | 2025-04-25 | — | — | CN | claimed |
| CN-119101232-B | Method and reaction device for on-line control of molecular weight of polyphenyl ether product | 上海优铖工逸技术有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-119101232-A | Method and reaction device for on-line control of molecular weight of polyphenyl ether product | 上海优铖工逸技术有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-114736367-A | Green and safe polyarylether gas-liquid heterogeneous synthesis method | 常州中英科技股份有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-114716666-A | Polyarylether synthesis method based on gas-liquid heterogeneous phase method and continuous flow microchannel reactor | 常州中英科技股份有限公司 | 2022-07-08 | — | — | CN | claimed |
| CN-108641077-B | Synthetic method of polyphenyl ether | 广东省石油与精细化工研究院 | 2020-07-28 | — | — | CN | claimed |
| EP-4695235-A1 | NOVEL GSPT1 DEGRADER AND USE THEREOF | Cyrus Therapeutics Inc. (KR) | 2026-02-18 | — | — | EP | disclosed |
| US-20260015459-A1 | Method for synthesizing polyphenylene ether | Chem Tech Solutions, LLC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12421349-B2 | Polyphenylene ether composition | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-09-23 | — | — | US | disclosed |
| EP-4282899-B1 | POLYPHENYLENE ETHER, PRODUCTION METHOD, THERMOSETTING COMPOSITION, PREPREG, AND LAMINATE THEREOF | ASAHI CHEMICAL IND (JP) | 2025-07-16 | — | — | EP | disclosed |
| WO-2025127084-A1 | RUBBER COMPOSITION AND METHOD FOR USING POLYPHENYLENE ETHER | 旭化成株式会社 | 2025-06-19 | — | — | WO | disclosed |
| EP-4342930-B1 | POLYPHENYLENE ETHER, PRODUCTION METHOD THEREFOR, THERMOSETTING COMPOSITION, PREPREG, AND MULTILAYER BODY | ASAHI CHEMICAL IND (JP) | 2025-06-11 | — | — | EP | disclosed |
| CN-87107289-A | The production method of polyphenylene oxide | — | 1988-06-15 | — | — | CN | disclosed |
| EP-0132608-B1 | PROCESS FOR THE POLYMERIZATION OF A 2,6-DISUBSTITUTED PHENOL | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1988-03-09 | — | — | EP | disclosed |
| US-4558119-A | WITH MANGANESE COMPOUND, N-ALKYLALKANOLAMINE, AND A BASIC COMPOUNDCATALYTIC MIXTURE | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1985-12-10 | — | — | US | disclosed |
| US-4532367-A | Antimicrobially effective derivatives of phenol and methods for their production | VEB JENAPHARM (DD) | 1985-07-30 | — | — | US | disclosed |
| EP-0132608-A1 | Process for the polymerization of a 2,6-disubstituted phenol | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1985-02-13 | — | — | EP | disclosed |
| EP-0069374-A2 | Phenolic compounds, process for their preparation and pharmaceutical compositions containing them | JENAPHARM GmbH (DE) | 1983-01-12 | — | — | EP | disclosed |
| US-4001426-A | HAVING CORONARY VASODILATOR ACTIVITY | SMITHKLINE CORPORATION (US) | 1977-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015459-A1 | Method for synthesizing polyphenylene ether | CYP2E1, HPD, ELL | GABRA1 3406/4885GABRB2 3243/4885CA2 3993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.